Funded Startups in Montreuil
Five recent funded rounds are listed for Montreuil, spanning from 2022-03-16 (BforCure) to 2026-02-03 (MyC), with two of the five closing after 2025-10-16…
Five recent funded rounds are listed for Montreuil, spanning from 2022-03-16 (BforCure) to 2026-02-03 (MyC), with two of the five closing after 2025-10-16 (Upciti on 2025-10-16 and MyC on 2026-02-03). The disclosed deal size distribution is uneven: Upciti’s $20M Series A (2025-10-16) is the largest disclosed amount and stands out against the rest, which cluster at $12M (MyC on 2026-02-03 and Spareka on 2023-03-07) and below, with Keewe at $1M (2022-05-05) the smallest disclosed round.
Sector-wise, the mix is concentrated in fintech-adjacent and healthcare/biotech themes: Financial Services (Keewe) and Data and Analytics (Upciti) each appear once, while Health Care (MyC) and Biotechnology (BforCure) account for two adjacent categories. Stage classifications also vary, with one entry labeled “Venture - Series Unknown” (BforCure, $9M on 2022-03-16) while the others split between Seed (Keewe, $1M) and Series A/B (Upciti $20M; MyC $12M; Spareka $12M).
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in Montreuil in this window, and how far ahead is it of the next-biggest deals?
Upciti’s $20M Series A on 2025-10-16 is the top disclosed amount; the next-largest disclosed rounds are $12M for MyC (2026-02-03) and Spareka (2023-03-07), while BforCure ($9M on 2022-03-16) and Keewe ($1M on 2022-05-05) sit materially below.
Do multiple rounds cluster in a narrow time window, or are they spread out across the period shown?
The five rows span 2022-03-16 to 2026-02-03, and there’s a noticeable late tail: two rounds after 2025-10-16 (Upciti $20M on 2025-10-16 and MyC $12M on 2026-02-03). The earlier entries are separated across 2022-03-16 (BforCure $9M), 2022-05-05 (Keewe $1M), and 2023-03-07 (Spareka $12M).
Is there an outlier in deal size or stage labeling worth flagging for deeper diligence?
Keewe is the low-end outlier on disclosed amount at $1M (Seed, 2022-05-05), while BforCure is an outlier on stage labeling: “Venture - Series Unknown” at $9M (2022-03-16). Upciti’s $20M (2025-10-16) also stands apart as the only disclosed round above $12M in this set.
How does the stage mix look across these five Montreuil entries?
Three entries use explicit round names (Seed for Keewe; Series A for MyC and Upciti; Series B for Spareka), while one entry is “Venture - Series Unknown” (BforCure, $9M on 2022-03-16). In this slice, Series A accounts for two of the five rows (MyC $12M on 2026-02-03; Upciti $20M on 2025-10-16).
Are certain sectors over-represented within this Montreuil list, compared with the single-occurrence categories?
Healthcare-adjacent themes appear twice: Health Care (MyC, 2026-02-03, $12M) and Biotechnology (BforCure, 2022-03-16, $9M). The remaining sectors in the five rows are single occurrences: Data and Analytics (Upciti, $20M), Commerce and Shopping (Spareka, $12M), and Financial Services (Keewe, $1M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.